IN2014CN02496A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN02496A IN2014CN02496A IN2496CHN2014A IN2014CN02496A IN 2014CN02496 A IN2014CN02496 A IN 2014CN02496A IN 2496CHN2014 A IN2496CHN2014 A IN 2496CHN2014A IN 2014CN02496 A IN2014CN02496 A IN 2014CN02496A
- Authority
- IN
- India
- Prior art keywords
- ovarian cancer
- identified
- biomarker
- therapies
- patient
- Prior art date
Links
- 206010033128 Ovarian cancer Diseases 0.000 abstract 2
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 101000737052 Homo sapiens Coiled-coil domain-containing protein 54 Proteins 0.000 abstract 1
- 101000824971 Homo sapiens Sperm surface protein Sp17 Proteins 0.000 abstract 1
- 102100022441 Sperm surface protein Sp17 Human genes 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161535309P | 2011-09-15 | 2011-09-15 | |
| PCT/US2012/054914 WO2013040071A2 (en) | 2011-09-15 | 2012-09-12 | Sperm protein as a detection biomarker of early stage ovarian cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN02496A true IN2014CN02496A (cs) | 2015-06-19 |
Family
ID=47883948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2496CHN2014 IN2014CN02496A (cs) | 2011-09-15 | 2012-09-12 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150110897A1 (cs) |
| EP (1) | EP2756100A4 (cs) |
| JP (1) | JP2014527816A (cs) |
| CN (1) | CN104039980A (cs) |
| CA (1) | CA2848578A1 (cs) |
| IN (1) | IN2014CN02496A (cs) |
| WO (1) | WO2013040071A2 (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104807997A (zh) * | 2015-05-05 | 2015-07-29 | 南京格耀生物科技有限公司 | 一种基于化学发光法检测ca125和sp17含量的试剂盒及方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002306600A1 (en) * | 2001-02-26 | 2002-09-12 | Albany Medical College | Sperm protein 17 for the diagnosis and treatment of cancer |
| US7189507B2 (en) * | 2001-06-18 | 2007-03-13 | Pdl Biopharma, Inc. | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| AT501348B1 (de) * | 2005-01-31 | 2008-10-15 | Vitateq Biotechnology Gmbh | Verfahren zur tumordiagnose |
| CN100334110C (zh) * | 2005-09-01 | 2007-08-29 | 中国人民解放军南京军区南京总医院 | 一种精子蛋白单克隆抗体及其制备方法和用途 |
| CA2630175C (en) * | 2005-11-16 | 2018-10-23 | Pantarhei Bioscience B.V. | Immunotherapeutic method for treating and/or preventing ovarian cancer |
-
2012
- 2012-09-12 CN CN201280054743.6A patent/CN104039980A/zh active Pending
- 2012-09-12 IN IN2496CHN2014 patent/IN2014CN02496A/en unknown
- 2012-09-12 CA CA 2848578 patent/CA2848578A1/en not_active Abandoned
- 2012-09-12 EP EP12831144.6A patent/EP2756100A4/en not_active Withdrawn
- 2012-09-12 WO PCT/US2012/054914 patent/WO2013040071A2/en active Application Filing
- 2012-09-12 US US14/345,208 patent/US20150110897A1/en not_active Abandoned
- 2012-09-12 JP JP2014530760A patent/JP2014527816A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20150110897A1 (en) | 2015-04-23 |
| EP2756100A2 (en) | 2014-07-23 |
| CA2848578A1 (en) | 2013-03-21 |
| WO2013040071A3 (en) | 2013-05-10 |
| EP2756100A4 (en) | 2015-05-13 |
| JP2014527816A (ja) | 2014-10-23 |
| CN104039980A (zh) | 2014-09-10 |
| WO2013040071A2 (en) | 2013-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276488B (en) | A method for predicting breast cancer prognosis | |
| TN2013000464A1 (en) | Biomarkers for hedgehog inhibitor therapy | |
| SG11201401386XA (en) | Treatment of hematologic malignancies with an anti-cxcr4 antibody | |
| MX370818B (es) | Anticuerpos anti-b7-h1 para tratar tumores. | |
| MX341734B (es) | Biomarcadores para la prediccion de la eficacia de una inmunoterapia contra el cancer. | |
| GEP201706612B (en) | Methods for the treatment of breast cancer | |
| GB201102014D0 (en) | Method for predicting risk of developing cancer | |
| EP2675485A4 (en) | ANTI-MUCIN ANTIBODY FOR THE EARLY RECOGNITION AND TREATMENT OF PANCREATIC CANCER | |
| HK1199290A1 (en) | Methods and compositions for the treatment and diagnosis of breast cancer | |
| ZA201403602B (en) | Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer | |
| IL232493A0 (en) | A method for quantifying cancer treatment | |
| IL238639A0 (en) | Methods for using biomarkers to treat cancer by regulating bcl2 expression | |
| GB2533873B (en) | Biomarkers useful for detection of types, grades and stages of human breast cancer | |
| PL2936151T3 (pl) | Sposoby leczenia i/lub ograniczania rozwoju cukrzycy | |
| IN2015DN01646A (cs) | ||
| AU2012371260A8 (en) | Predicitive biomarker for cancer treatment with ADCC enhanced antibodies | |
| PH12014502461A1 (en) | Biomarkers for iap inhibitor therapy | |
| HUE045368T2 (hu) | Prosztatarák kezelése és eljárás prosztatarák páciensek prognózisának meghatározására | |
| IN2014CN02496A (cs) | ||
| UA77502U (ru) | Способ прогнозирования течения бронхиальной астмы | |
| UA82096U (ru) | Способ прогнозирования развития рефрактур | |
| UA111952C2 (uk) | Біомаркер для передбачення результату протиракової імунотерапії |